Artificial Intelligence (AI) in Life Sciences Market Size & Growth

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Artificial Intelligence (AI) in Life Sciences Market Size Analysis

Global Artificial Intelligence (AI) in Life Sciences Market Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Machine Learning (ML)
  1. By Value
3. Deep Learning (DL)
  1. By Value
4. Natural Language Processing (NLP)
  1. By Value
5. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Drug Discovery
  1. By Value
3. Medical Diagnosis
  1. By Value
4. Biotechnology
  1. By Value
5. Clinical Trials
  1. By Value
6. Precision and Personalized Medicine
  1. By Value
7. Patient Monitoring
  1. By Value
8. Novel Drug Candidates
  1. By Value
9. Drug Optimization and Repurposing Preclinical Testing and Approval
  1. By Value
10. Drug Monitoring
  1. By Value
11. Finding New Diseases Associated Targets and Pathways
  1. By Value
12. Understanding Disease Mechanisms
  1. By Value
13. Aggregating and Synthesizing Information
  1. By Value
14. Formation & Qualification of Hypotheses
  1. By Value
15. De Novo Drug Design
  1. By Value
16. Finding Drug Targets of an Old Drug
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Small Molecule
  1. By Value
3. Large Molecule
  1. By Value
By Offering
1. Introduction
  1. Offering By Value
2. Software
  1. By Value
3. Services
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Immuno-Oncology
  1. By Value
3. Neurodegenerative Diseases
  1. By Value
4. Cardiovascular Diseases
  1. By Value
5. Metabolic Diseases
  1. By Value
6. Others
  1. By Value
By End user
1. Introduction
  1. End user By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Contract Research Organizations (CROs)
  1. By Value
4. Research Centres And Academic Institutes
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Machine Learning (ML)
  1. By Value
3. Deep Learning (DL)
  1. By Value
4. Natural Language Processing (NLP)
  1. By Value
5. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Drug Discovery
  1. By Value
3. Medical Diagnosis
  1. By Value
4. Biotechnology
  1. By Value
5. Clinical Trials
  1. By Value
6. Precision and Personalized Medicine
  1. By Value
7. Patient Monitoring
  1. By Value
8. Novel Drug Candidates
  1. By Value
9. Drug Optimization and Repurposing Preclinical Testing and Approval
  1. By Value
10. Drug Monitoring
  1. By Value
11. Finding New Diseases Associated Targets and Pathways
  1. By Value
12. Understanding Disease Mechanisms
  1. By Value
13. Aggregating and Synthesizing Information
  1. By Value
14. Formation & Qualification of Hypotheses
  1. By Value
15. De Novo Drug Design
  1. By Value
16. Finding Drug Targets of an Old Drug
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Small Molecule
  1. By Value
3. Large Molecule
  1. By Value
By Offering
1. Introduction
  1. Offering By Value
2. Software
  1. By Value
3. Services
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Immuno-Oncology
  1. By Value
3. Neurodegenerative Diseases
  1. By Value
4. Cardiovascular Diseases
  1. By Value
5. Metabolic Diseases
  1. By Value
6. Others
  1. By Value
By End user
1. Introduction
  1. End user By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Contract Research Organizations (CROs)
  1. By Value
4. Research Centres And Academic Institutes
  1. By Value
5. Others
  1. By Value
U.S.
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Machine Learning (ML)
    1. By Value
  3. Deep Learning (DL)
    1. By Value
  4. Natural Language Processing (NLP)
    1. By Value
  5. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Drug Discovery
    1. By Value
  3. Medical Diagnosis
    1. By Value
  4. Biotechnology
    1. By Value
  5. Clinical Trials
    1. By Value
  6. Precision and Personalized Medicine
    1. By Value
  7. Patient Monitoring
    1. By Value
  8. Novel Drug Candidates
    1. By Value
  9. Drug Optimization and Repurposing Preclinical Testing and Approval
    1. By Value
  10. Drug Monitoring
    1. By Value
  11. Finding New Diseases Associated Targets and Pathways
    1. By Value
  12. Understanding Disease Mechanisms
    1. By Value
  13. Aggregating and Synthesizing Information
    1. By Value
  14. Formation & Qualification of Hypotheses
    1. By Value
  15. De Novo Drug Design
    1. By Value
  16. Finding Drug Targets of an Old Drug
    1. By Value
3. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Small Molecule
    1. By Value
  3. Large Molecule
    1. By Value
4. By Offering
  1. Introduction
    1. Offering By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
5. By Indication
  1. Introduction
    1. Indication By Value
  2. Immuno-Oncology
    1. By Value
  3. Neurodegenerative Diseases
    1. By Value
  4. Cardiovascular Diseases
    1. By Value
  5. Metabolic Diseases
    1. By Value
  6. Others
    1. By Value
6. By End user
  1. Introduction
    1. End user By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Contract Research Organizations (CROs)
    1. By Value
  4. Research Centres And Academic Institutes
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Machine Learning (ML)
  1. By Value
3. Deep Learning (DL)
  1. By Value
4. Natural Language Processing (NLP)
  1. By Value
5. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Drug Discovery
  1. By Value
3. Medical Diagnosis
  1. By Value
4. Biotechnology
  1. By Value
5. Clinical Trials
  1. By Value
6. Precision and Personalized Medicine
  1. By Value
7. Patient Monitoring
  1. By Value
8. Novel Drug Candidates
  1. By Value
9. Drug Optimization and Repurposing Preclinical Testing and Approval
  1. By Value
10. Drug Monitoring
  1. By Value
11. Finding New Diseases Associated Targets and Pathways
  1. By Value
12. Understanding Disease Mechanisms
  1. By Value
13. Aggregating and Synthesizing Information
  1. By Value
14. Formation & Qualification of Hypotheses
  1. By Value
15. De Novo Drug Design
  1. By Value
16. Finding Drug Targets of an Old Drug
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Small Molecule
  1. By Value
3. Large Molecule
  1. By Value
By Offering
1. Introduction
  1. Offering By Value
2. Software
  1. By Value
3. Services
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Immuno-Oncology
  1. By Value
3. Neurodegenerative Diseases
  1. By Value
4. Cardiovascular Diseases
  1. By Value
5. Metabolic Diseases
  1. By Value
6. Others
  1. By Value
By End user
1. Introduction
  1. End user By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Contract Research Organizations (CROs)
  1. By Value
4. Research Centres And Academic Institutes
  1. By Value
5. Others
  1. By Value
U.K.
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Machine Learning (ML)
    1. By Value
  3. Deep Learning (DL)
    1. By Value
  4. Natural Language Processing (NLP)
    1. By Value
  5. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Drug Discovery
    1. By Value
  3. Medical Diagnosis
    1. By Value
  4. Biotechnology
    1. By Value
  5. Clinical Trials
    1. By Value
  6. Precision and Personalized Medicine
    1. By Value
  7. Patient Monitoring
    1. By Value
  8. Novel Drug Candidates
    1. By Value
  9. Drug Optimization and Repurposing Preclinical Testing and Approval
    1. By Value
  10. Drug Monitoring
    1. By Value
  11. Finding New Diseases Associated Targets and Pathways
    1. By Value
  12. Understanding Disease Mechanisms
    1. By Value
  13. Aggregating and Synthesizing Information
    1. By Value
  14. Formation & Qualification of Hypotheses
    1. By Value
  15. De Novo Drug Design
    1. By Value
  16. Finding Drug Targets of an Old Drug
    1. By Value
3. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Small Molecule
    1. By Value
  3. Large Molecule
    1. By Value
4. By Offering
  1. Introduction
    1. Offering By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
5. By Indication
  1. Introduction
    1. Indication By Value
  2. Immuno-Oncology
    1. By Value
  3. Neurodegenerative Diseases
    1. By Value
  4. Cardiovascular Diseases
    1. By Value
  5. Metabolic Diseases
    1. By Value
  6. Others
    1. By Value
6. By End user
  1. Introduction
    1. End user By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Contract Research Organizations (CROs)
    1. By Value
  4. Research Centres And Academic Institutes
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Machine Learning (ML)
  1. By Value
3. Deep Learning (DL)
  1. By Value
4. Natural Language Processing (NLP)
  1. By Value
5. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Drug Discovery
  1. By Value
3. Medical Diagnosis
  1. By Value
4. Biotechnology
  1. By Value
5. Clinical Trials
  1. By Value
6. Precision and Personalized Medicine
  1. By Value
7. Patient Monitoring
  1. By Value
8. Novel Drug Candidates
  1. By Value
9. Drug Optimization and Repurposing Preclinical Testing and Approval
  1. By Value
10. Drug Monitoring
  1. By Value
11. Finding New Diseases Associated Targets and Pathways
  1. By Value
12. Understanding Disease Mechanisms
  1. By Value
13. Aggregating and Synthesizing Information
  1. By Value
14. Formation & Qualification of Hypotheses
  1. By Value
15. De Novo Drug Design
  1. By Value
16. Finding Drug Targets of an Old Drug
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Small Molecule
  1. By Value
3. Large Molecule
  1. By Value
By Offering
1. Introduction
  1. Offering By Value
2. Software
  1. By Value
3. Services
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Immuno-Oncology
  1. By Value
3. Neurodegenerative Diseases
  1. By Value
4. Cardiovascular Diseases
  1. By Value
5. Metabolic Diseases
  1. By Value
6. Others
  1. By Value
By End user
1. Introduction
  1. End user By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Contract Research Organizations (CROs)
  1. By Value
4. Research Centres And Academic Institutes
  1. By Value
5. Others
  1. By Value
China
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Machine Learning (ML)
    1. By Value
  3. Deep Learning (DL)
    1. By Value
  4. Natural Language Processing (NLP)
    1. By Value
  5. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Drug Discovery
    1. By Value
  3. Medical Diagnosis
    1. By Value
  4. Biotechnology
    1. By Value
  5. Clinical Trials
    1. By Value
  6. Precision and Personalized Medicine
    1. By Value
  7. Patient Monitoring
    1. By Value
  8. Novel Drug Candidates
    1. By Value
  9. Drug Optimization and Repurposing Preclinical Testing and Approval
    1. By Value
  10. Drug Monitoring
    1. By Value
  11. Finding New Diseases Associated Targets and Pathways
    1. By Value
  12. Understanding Disease Mechanisms
    1. By Value
  13. Aggregating and Synthesizing Information
    1. By Value
  14. Formation & Qualification of Hypotheses
    1. By Value
  15. De Novo Drug Design
    1. By Value
  16. Finding Drug Targets of an Old Drug
    1. By Value
3. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Small Molecule
    1. By Value
  3. Large Molecule
    1. By Value
4. By Offering
  1. Introduction
    1. Offering By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
5. By Indication
  1. Introduction
    1. Indication By Value
  2. Immuno-Oncology
    1. By Value
  3. Neurodegenerative Diseases
    1. By Value
  4. Cardiovascular Diseases
    1. By Value
  5. Metabolic Diseases
    1. By Value
  6. Others
    1. By Value
6. By End user
  1. Introduction
    1. End user By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Contract Research Organizations (CROs)
    1. By Value
  4. Research Centres And Academic Institutes
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Machine Learning (ML)
  1. By Value
3. Deep Learning (DL)
  1. By Value
4. Natural Language Processing (NLP)
  1. By Value
5. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Drug Discovery
  1. By Value
3. Medical Diagnosis
  1. By Value
4. Biotechnology
  1. By Value
5. Clinical Trials
  1. By Value
6. Precision and Personalized Medicine
  1. By Value
7. Patient Monitoring
  1. By Value
8. Novel Drug Candidates
  1. By Value
9. Drug Optimization and Repurposing Preclinical Testing and Approval
  1. By Value
10. Drug Monitoring
  1. By Value
11. Finding New Diseases Associated Targets and Pathways
  1. By Value
12. Understanding Disease Mechanisms
  1. By Value
13. Aggregating and Synthesizing Information
  1. By Value
14. Formation & Qualification of Hypotheses
  1. By Value
15. De Novo Drug Design
  1. By Value
16. Finding Drug Targets of an Old Drug
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Small Molecule
  1. By Value
3. Large Molecule
  1. By Value
By Offering
1. Introduction
  1. Offering By Value
2. Software
  1. By Value
3. Services
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Immuno-Oncology
  1. By Value
3. Neurodegenerative Diseases
  1. By Value
4. Cardiovascular Diseases
  1. By Value
5. Metabolic Diseases
  1. By Value
6. Others
  1. By Value
By End user
1. Introduction
  1. End user By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Contract Research Organizations (CROs)
  1. By Value
4. Research Centres And Academic Institutes
  1. By Value
5. Others
  1. By Value
UAE
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Machine Learning (ML)
    1. By Value
  3. Deep Learning (DL)
    1. By Value
  4. Natural Language Processing (NLP)
    1. By Value
  5. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Drug Discovery
    1. By Value
  3. Medical Diagnosis
    1. By Value
  4. Biotechnology
    1. By Value
  5. Clinical Trials
    1. By Value
  6. Precision and Personalized Medicine
    1. By Value
  7. Patient Monitoring
    1. By Value
  8. Novel Drug Candidates
    1. By Value
  9. Drug Optimization and Repurposing Preclinical Testing and Approval
    1. By Value
  10. Drug Monitoring
    1. By Value
  11. Finding New Diseases Associated Targets and Pathways
    1. By Value
  12. Understanding Disease Mechanisms
    1. By Value
  13. Aggregating and Synthesizing Information
    1. By Value
  14. Formation & Qualification of Hypotheses
    1. By Value
  15. De Novo Drug Design
    1. By Value
  16. Finding Drug Targets of an Old Drug
    1. By Value
3. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Small Molecule
    1. By Value
  3. Large Molecule
    1. By Value
4. By Offering
  1. Introduction
    1. Offering By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
5. By Indication
  1. Introduction
    1. Indication By Value
  2. Immuno-Oncology
    1. By Value
  3. Neurodegenerative Diseases
    1. By Value
  4. Cardiovascular Diseases
    1. By Value
  5. Metabolic Diseases
    1. By Value
  6. Others
    1. By Value
6. By End user
  1. Introduction
    1. End user By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Contract Research Organizations (CROs)
    1. By Value
  4. Research Centres And Academic Institutes
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Machine Learning (ML)
  1. By Value
3. Deep Learning (DL)
  1. By Value
4. Natural Language Processing (NLP)
  1. By Value
5. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Drug Discovery
  1. By Value
3. Medical Diagnosis
  1. By Value
4. Biotechnology
  1. By Value
5. Clinical Trials
  1. By Value
6. Precision and Personalized Medicine
  1. By Value
7. Patient Monitoring
  1. By Value
8. Novel Drug Candidates
  1. By Value
9. Drug Optimization and Repurposing Preclinical Testing and Approval
  1. By Value
10. Drug Monitoring
  1. By Value
11. Finding New Diseases Associated Targets and Pathways
  1. By Value
12. Understanding Disease Mechanisms
  1. By Value
13. Aggregating and Synthesizing Information
  1. By Value
14. Formation & Qualification of Hypotheses
  1. By Value
15. De Novo Drug Design
  1. By Value
16. Finding Drug Targets of an Old Drug
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Small Molecule
  1. By Value
3. Large Molecule
  1. By Value
By Offering
1. Introduction
  1. Offering By Value
2. Software
  1. By Value
3. Services
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Immuno-Oncology
  1. By Value
3. Neurodegenerative Diseases
  1. By Value
4. Cardiovascular Diseases
  1. By Value
5. Metabolic Diseases
  1. By Value
6. Others
  1. By Value
By End user
1. Introduction
  1. End user By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Contract Research Organizations (CROs)
  1. By Value
4. Research Centres And Academic Institutes
  1. By Value
5. Others
  1. By Value
Brazil
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Machine Learning (ML)
    1. By Value
  3. Deep Learning (DL)
    1. By Value
  4. Natural Language Processing (NLP)
    1. By Value
  5. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Drug Discovery
    1. By Value
  3. Medical Diagnosis
    1. By Value
  4. Biotechnology
    1. By Value
  5. Clinical Trials
    1. By Value
  6. Precision and Personalized Medicine
    1. By Value
  7. Patient Monitoring
    1. By Value
  8. Novel Drug Candidates
    1. By Value
  9. Drug Optimization and Repurposing Preclinical Testing and Approval
    1. By Value
  10. Drug Monitoring
    1. By Value
  11. Finding New Diseases Associated Targets and Pathways
    1. By Value
  12. Understanding Disease Mechanisms
    1. By Value
  13. Aggregating and Synthesizing Information
    1. By Value
  14. Formation & Qualification of Hypotheses
    1. By Value
  15. De Novo Drug Design
    1. By Value
  16. Finding Drug Targets of an Old Drug
    1. By Value
3. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Small Molecule
    1. By Value
  3. Large Molecule
    1. By Value
4. By Offering
  1. Introduction
    1. Offering By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
5. By Indication
  1. Introduction
    1. Indication By Value
  2. Immuno-Oncology
    1. By Value
  3. Neurodegenerative Diseases
    1. By Value
  4. Cardiovascular Diseases
    1. By Value
  5. Metabolic Diseases
    1. By Value
  6. Others
    1. By Value
6. By End user
  1. Introduction
    1. End user By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Contract Research Organizations (CROs)
    1. By Value
  4. Research Centres And Academic Institutes
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Artificial Intelligence (AI) in Life Sciences Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

NuMedii Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Atomwise Inc.
IBM Corporation
AiCure LLC
Nuance Communications Inc.
Sensely Inc.
Sophia Genetics SA
Insilico Medicine Inc.
Enlitic Inc.
Apixio Inc.
Zebra Medical Vision
twoXAR Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment